Concepedia

Publication | Closed Access

2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.

DOI

17

Citations

0

References

2024

Year

E. Sebbag, Kim Lauper, J. Molina Collada, Daniel Aletaha, Johan Askling, Karolina Gente, Heidi Bertheussen, Samuel Bitoun, Ertuğrul Çağrı Bölek, Gerd R Burmester,
PubMed

Abstract

The 2024 EULAR points to consider provide guidance on the management of targeted therapies in patients with IA and a previous malignancy.